|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Dr. Wolfgang Knirsch||Chairman of Management Board & CEO||387k||N/D||1960|
|Mr. Falk Neukirch||CFO & Member of Management Board||217k||N/D||1971|
|Santiago Luengo||Managing Director of Secuvita||N/D||N/D||N/D|
VITA 34 AG engages in the collection, preparation, and storage of stem cells from umbilical cord blood and tissue in Europe. It offers VitaMine&Yours for the preparation of umbilical cord tissue for use in cryo-preservation; VitaPlusDonation product has a personal stem cell deposit stored for personal health care use; and Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes. The company also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is headquartered in Leipzig, Germany.
L'ISS Governance QualityScore di VITA 34 AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.